Pictet Asset Management’s Centessa Pharmaceuticals CNTA Stock Holding History

Pictet Asset Management’s Portfolio CNTA Stock Details CNTA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-96,910	Closed	-$2.67M	–	2156
2026 Q1	$2.67M	Buy	+96,910	New	+$2.48M	﹤0.01%	856
2025 Q4	–	Sell	-13,869	Closed	-$336K	–	2089
2025 Q3	$336K	Buy	+13,869	New	+$247K	﹤0.01%	1588

Pictet Asset Management's CNTA Position: Q2 2026 in Review

Pictet Asset Management sold out of Centessa Pharmaceuticals (CNTA) in Q2 2026, closing a stake of 96,910 shares — an estimated $2.67M sold.

Pictet Asset Management first reported a position in CNTA in Q3 2025 and held it in 2 quarters. The position peaked at $2.67M in Q1 2026. 0 funds tracked by Wall St. Rank hold CNTA as of Q2 2026.

Pictet Asset Management reported no remaining Centessa Pharmaceuticals position as of Q2 2026 after selling out during the quarter.
Pictet Asset Management sold 96,910 Centessa Pharmaceuticals shares in Q2 2026, an estimated $2.67M.
Pictet Asset Management first reported a position in Centessa Pharmaceuticals in Q3 2025 and held it in 2 quarters.
Pictet Asset Management's Centessa Pharmaceuticals position peaked at $2.67M in Q1 2026.
0 funds tracked by Wall St. Rank held Centessa Pharmaceuticals as of Q2 2026.

Based on Pictet Asset Management's 13F filing for Q2 2026, filed 30 Jul 2026.